Central Pacific Bank - Trust Division’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8K Sell
417
-5,433
-93% -$295K ﹤0.01% 682
2026
Q1
$367K Sell
5,850
-22,664
-79% -$1.81M 0.05% 339
2025
Q4
$2.72M Sell
28,514
-1,993
-7% -$195K 0.33% 70
2025
Q3
$2.98M Sell
30,507
-253
-0.8% -$26.2K 0.36% 70
2025
Q2
$3.3M Buy
30,760
+259
+0.8% +$26.2K 0.42% 62
2025
Q1
$3.08M Buy
30,501
+3,575
+13% +$360K 0.43% 54
2024
Q4
$2.41M Sell
26,926
-957
-3% -$84.2K 0.31% 69
2024
Q3
$2.34M Buy
27,883
+2,677
+11% +$211K 0.29% 84
2024
Q2
$1.94M Sell
25,206
-1,460
-5% -$107K 0.23% 98
2024
Q1
$1.82M Buy
+26,666
New +$1.71M 0.23% 113

Other funds holding BSX

Central Pacific Bank - Trust Division's BSX Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its Boston Scientific (BSX) stake by 93% in Q2 2026, selling an estimated $295K and leaving 417 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Central Pacific Bank - Trust Division first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.3M in Q2 2025. 303 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Central Pacific Bank - Trust Division held 417 shares of Boston Scientific worth $17.8K as of Q2 2026.
  • Central Pacific Bank - Trust Division sold 5,433 Boston Scientific shares in Q2 2026, an estimated $295K.
  • Boston Scientific made up ﹤0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #682 holding.
  • Central Pacific Bank - Trust Division first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Boston Scientific position peaked at $3.3M in Q2 2025.
  • 303 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.